Rigel Pharmaceuticals (RIGL) Operating Leases (2019 - 2026)
Rigel Pharmaceuticals' quarterly Operating Leases came in at $228000.0 in Q1 2026, down 73.61% year-on-year from $864000.0 in Q1 2025, and down 42.28% quarter-over-quarter from $395000.0 in Q4 2025.
Rigel Pharmaceuticals has reported Operating Leases for 8 years, with the latest figure at $228000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 73.61% year-over-year to $228000.0; the trailing twelve-month figure through Mar 2026 stood at $228000.0 (down 73.61% YoY), and the FY2025 full-year result was $395000.0, changed N/A from the prior year.
- Operating Leases for Q1 2026 stood at $228000.0, down from $395000.0 in the prior quarter.
- The five-year high for Operating Leases was $8.3 million in Q1 2022, with the low at $100000.0 in Q1 2024.
- Average Operating Leases over 5 years is $1.2 million, with a median of $592000.0 recorded in 2023.
- Year-over-year, Operating Leases tumbled 90.34% in 2023 and soared 764.0% in 2025.
- Tracing RIGL's Operating Leases over 5 years: stood at $972000.0 in 2022, then slumped by 70.68% to $285000.0 in 2023, then plunged by 64.91% to $100000.0 in 2024, then soared by 295.0% to $395000.0 in 2025, then slumped by 42.28% to $228000.0 in 2026.
- The last three Operating Leases figures came in at $228000.0 (Q1 2026), $395000.0 (Q4 2025), and $556000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 556,000.00 |
| Jun 30, 2025 | 714,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Sep 30, 2023 | 466,000.00 |
| Jun 30, 2023 | 628,000.00 |
| Mar 31, 2023 | 802,000.00 |
| Dec 31, 2022 | 972,000.00 |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 759,000.00 |
| Sep 30, 2021 | 12.90 Mn |
| Jun 30, 2021 | 5.85 Mn |
| Mar 31, 2021 | 17.20 Mn |
| Dec 31, 2020 | 19.30 Mn |
| Sep 30, 2020 | 12.93 Mn |
| Jun 30, 2020 | 15.25 Mn |
| Mar 31, 2020 | 17.31 Mn |
| Dec 31, 2019 | 19.23 Mn |
| Sep 30, 2019 | 21.18 Mn |
| Jun 30, 2019 | 23.09 Mn |
| Mar 31, 2019 | 24.95 Mn |